bio reference lab patient portal

Why choose BioReference for prostate cancer diagnostics?

From clinical routine to esoteric assays, BioReference’s expansive test menu aids healthcare providers in the diagnosis, monitoring and treatment of disease for their patients. The 4Kscore® Test helps clarify the biopsy decision-making process by determining a patient-specific probability for finding aggressive prostate cancer.

How do I view my BioReference test results?

View your BioReference test results in the Apple Health app on iPhone* or CommonHealth app on Android devices. It’s easy to view your laboratory test results in the same place as your other important health information. Learn how to get started today.

How do I become a BioReference client?

If you are interested in becoming a BioReference client, please use the form below to request a visit to your office by one of our sales account executives to discuss your service needs. Your dedicated representative will be pleased to provide you with:

What is the age limit for the BioReference Omicron test?

This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or abnormal digital rectal exam (DRE). BioReference announced COVID-19 testing preparedness for the Omicron Variant.

The laboratory at your fingertips

BioReference is empowering patients with knowledge to enhance engagement in their healthcare journey through digitally enabled, secure, and on-demand solutions.

COVID-19 Game Plan

The days are getting shorter, there is a cool crisp in the air, and the leaves are changing colors; it’s undoubtedly fall. The return of the autumnal season also means football has kicked-off, baseball playoffs are here, basketball is just beginning, hockey players are ready to hit the ice, and soccer teams have rivalry match-ups.

NBA to primarily use rapid tests for COVID-19 in 2021-22

Given the league’s high vaccination rate, the NBA’s primary form of COVID-19 detection this season will center on designated team officials — largely members of the medical staff — using small, at-home, molecular-based testing devices that can return results in 20 minutes.